课题基金 / 基金详情

International comparison research on euthanasia, assisted suicide, and palliative care of line withering amyotrophic lateral sclerosis (ALS)

International comparison research on euthanasia, assisted suicide, and palliative care of line withering amyotrophic lateral sclerosis (ALS)
萎缩性肌萎缩侧索硬化症(ALS)安乐死、协助自杀和姑息治疗的国际比较研究
批准号:
11672239
负责人:
ITO Michiya
金额:
$1.09万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

ITO Michiya的其他基金

相似基金

相关文献

中文摘要
翻译
关于自身ALS(肌萎缩性侧索硬化症)临终医疗状态“积极与疾病抗争”占25.7%,“姑息治疗”占16.0%。“协助自杀”9.2%,“主动安乐死”42.7%,“其他”6.3%,“爱的人”相似并依附。“积极与疾病抗争”27.7%,“姑息治疗”13.0%,“协助自杀”6.8%,“主动安乐死”33.5%,“其他”118.9%。”。“自己”和“爱人”对“主动安乐死”的期望均高于技术系统学生<医疗福利系统学生(p<0.01)和男性<女性(p<0.01)。“积极与疾病抗争”的技校生>高于医疗福利系学生> (p<0.01),男生>高于女生(p<0.01)。更希望“主动安乐死”。“自己”“爱的人”(p<0.001)。多元回归分析表明,目的变量为“爱的人”关怀的第二种应然回复,尤其具有显著性(r=0.50, p=0.0015)。“自己”是第二个“自己”的选择(r=0.35, p=0.005)。坚持渐冻症和有医学知识的人是法律禁止的。“主动安乐死”这是相似的,肯定的事情被建议。此外,《爱的人》的倾向,这是在符合自己的情况下作出的,是关于关怀的考虑也变得清晰起来。反复附加和教育“姑息治疗”和“与顽固性疾病积极斗争的意义”,被认为可以避免医福利学生的悲观情绪。
英文摘要
About the state of oneself ALS(amyotrophic lateral sclerosis) end term medical treatment “Positive struggle against disease" 25.7%, “Palliative care" 16.0%. “Assisted suicide" 9.2%, “Active euthanasia" 42.7%, “Others" 6.3%, “Those who love" It is alike and attaches. “Positive struggle against disease" 27.7%, “Palliative care" 13.0%, “Assisted suicide" 6.8%, “Active euthanasia" 33.5%, “Others" 118.9%. “.Both" Oneself “and" Those who love “to hope" Active euthanasia “is higher the technical system students < medical welfare system students (p<0.01) and male < female (p<0.01)." Positive struggle against disease “is higher the technical system students > medical welfare system students (p<0.01) and male > female (p<0.01).Moreover to hope “Active euthanasia",. “Oneself" > “Those who love" (p<0.001).According to the maltiple regression analysis which made the purpose variable the 2nd way-that-should-be reply of care for “Those who love", it is especially a significant item (r=0.50, p=0.0015). “Oneself" It was selection (r=0.35, p=0.005) of the 2nd “Oneself".The way which sticks ALS and has medical knowledge is forbidden law. “Active euthanasia" It was alike and the affirmative thing was suggested.Moreover “Those who love" the tendency which is made in agreement with its own case, and is considered about care also became clear.It was considered to lead to avoiding the pessimism of the medical welfare students concerned to attach and educate “Palliative care" and “Meaning of a positive struggle against intractable disease" repeatedly.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
On Genetic diagnosis guideline.
关于基因诊断指南。
DOI: --
发表时间: 2000
期刊: The EBM Journal 2 (1)
影响因子: --
作者: [Michiya ITO, Soichiro YAMAZAKI, et al, Michiya ITO]
通讯作者: Michiya ITO
伊藤 道哉: "チーム医療とクリティカルパス"プラクティス. 16・4. 388-392 (1999)
伊藤道也:“团队医疗和关键路径”实践16・4(1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间: 2000
期刊: 生命倫理 10(1)
影响因子: --
作者: [伊藤 道哉, 山崎壮一郎, 他]
通讯作者: 他
遺伝子素因診断の倫理と経済
遗传易感性诊断的伦理学和经济学
DOI: --
发表时间: 2000
期刊: 東北医学雑誌 112
影响因子: --
作者: [伊藤 道哉, 山崎壮一郎, 他, 伊藤 道哉, 伊藤 道哉]
通讯作者: 伊藤 道哉
共 24 条
    Research on the diffusion of Advance directives of ALS (Amyotrophic lateral sclerosis) patients by designation as Proxy decision maker
    Ethical and social study on the care for ALS-D (ALS with dementia) patients and thier family
    • 批准号:
      25670239
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      ITO Michiya
    • 依托单位:
    Socio-medical research on the effects of the legalization to discontinue life-sustaining treatment
    • 批准号:
      23659248
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.16万
    • 财政年份:
      2011
    • 负责人:
      ITO Michiya
    • 依托单位:
    Research on Advance directives of Amyotrophic Lateral sclerosis Patient and QOL
    • 批准号:
      16590417
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $0.9万
    • 财政年份:
      2004
    • 负责人:
      ITO Michiya
    • 依托单位:
    海外基金